touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Supporting patients with HER2-positive colorectal cancer

    touchMDT for touchONCOLOGY

    A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer.

    The multidisciplinary team:

    • Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA
  • Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA
  • Patient advocate: Mr Scott Wilson, Denver, CO, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

    14 min
  • Utilizing HER2-targeted treatments in colorectal cancer

    touchMDT for touchONCOLOGY

    Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC.

    The multidisciplinary team:

    • Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

    14 min
  • Navigating the complexities of the NSCLC treatment pathway: A focus on antibody-drug conjugates

    touchPANEL DISCUSSION for touchONCOLOGY

    Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC. 

    The experts:

    • Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland
  • Dr Rebecca Heist, Massachusetts General Hospital Cancer Center, Boston, MA, USA
  • Dr Antonio Passaro, European Institute of Oncology, Milan, Italy

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an independent medical education grant from AstraZeneca. This activity is provided by touchIME. 

    For further information please visit: https://touchoncology.com/education/pd-navigating-the-nsclc-treatment-pathway-focus-on-adcs/

    33 min
  • Higher-risk MDS: An update on emerging novel agents

    touchTALKS for touchONCOLOGY

    Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. Dr David Sallman covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety.

    The expert:

    • Dr David Sallman, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/hr-mds-emerging-treatments/

    35 min
  • Supporting families to optimize outcomes

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. 

    The multidisciplinary team

    • Paediatric immunologist: Dr Wanda Phipatanakul
  • Primary care physician: Dr Ioanna Tsiligianni
  • Specialist asthma nurse: Ms Viv Marsh
  • Patient advocate: Ms Monique Cooper

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and  Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

    14 min
  • Supporting families to optimize outcomes

    touchMDT for touchIMMUNOLOGY

    Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. 

    The multidisciplinary team:

    • Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
  • Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
  • Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK
  • Patient advocate: Ms Monique Cooper, Miami, FL, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

    14 min
  • The role of the MDT in managing paediatric severe type 2 asthma

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.

    The multidisciplinary team

    • Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
  • Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
  • Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
  • Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and  Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

    14 min
  • The role of the MDT in managing paediatric severe type 2 asthma

    touchMDT for touchIMMUNOLOGY

    Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.

    The multidisciplinary team:

    • Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
  • Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
  • Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
  • Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

    14 min
  • The use of biologics in children with severe type 2 asthma

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.

    The multidisciplinary team:

    • Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
  • Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
  • Patient advocate: Ms Monique Cooper, Miami, FL, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

    14 min
  • The use of biologics in children with severe type 2 asthma

    touchMDT for touchIMMUNOLOGY

    Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.

    The multidisciplinary team:

    • Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
  • Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
  • Patient advocate: Ms Monique Cooper, Miami, FL, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma

    14 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.